These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18481868)

  • 1. Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity.
    Eriksson U; Peterson LW; Kashemirov BA; Hilfinger JM; Drach JC; Borysko KZ; Breitenbach JM; Kim JS; Mitchell S; Kijek P; McKenna CE
    Mol Pharm; 2008; 5(4):598-609. PubMed ID: 18481868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.
    Peterson LW; Kim JS; Kijek P; Mitchell S; Hilfinger J; Breitenbach J; Borysko K; Drach JC; Kashemirov BA; McKenna CE
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4045-9. PubMed ID: 21641218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1.
    Peterson LW; Sala-Rabanal M; Krylov IS; Serpi M; Kashemirov BA; McKenna CE
    Mol Pharm; 2010 Dec; 7(6):2349-61. PubMed ID: 20929265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies.
    Zakharova VM; Serpi M; Krylov IS; Peterson LW; Breitenbach JM; Borysko KZ; Drach JC; Collins M; Hilfinger JM; Kashemirov BA; McKenna CE
    J Med Chem; 2011 Aug; 54(16):5680-93. PubMed ID: 21812420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir.
    Eriksson U; Hilfinger JM; Kim JS; Mitchell S; Kijek P; Borysko KZ; Breitenbach JM; Drach JC; Kashemirov BA; McKenna CE
    Bioorg Med Chem Lett; 2007 Feb; 17(3):583-6. PubMed ID: 17161946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puromycin-sensitive aminopeptidase: an antiviral prodrug activating enzyme.
    Tehler U; Nelson CH; Peterson LW; Provoda CJ; Hilfinger JM; Lee KD; McKenna CE; Amidon GL
    Antiviral Res; 2010 Mar; 85(3):482-9. PubMed ID: 19969024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity.
    Krečmerová M; Pohl R; Masojídková M; Balzarini J; Snoeck R; Andrei G
    Bioorg Med Chem; 2014 May; 22(10):2896-906. PubMed ID: 24731540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stability.
    Oliyai R; Shaw JP; Sueoka-Lennen CM; Cundy KC; Arimilli MN; Jones RJ; Lee WA
    Pharm Res; 1999 Nov; 16(11):1687-93. PubMed ID: 10571273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase.
    Mendel DB; Cihlar T; Moon K; Chen MS
    Antimicrob Agents Chemother; 1997 Mar; 41(3):641-6. PubMed ID: 9056007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New prodrugs of Adefovir and Cidofovir.
    Tichý T; Andrei G; Dračínský M; Holý A; Balzarini J; Snoeck R; Krečmerová M
    Bioorg Med Chem; 2011 Jun; 19(11):3527-39. PubMed ID: 21565516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine.
    Ruiz J; Beadle JR; Buller RM; Schreiwer J; Prichard MN; Keith KA; Lewis KC; Hostetler KY
    Bioorg Med Chem; 2011 May; 19(9):2950-8. PubMed ID: 21493074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo.
    Bischofberger N; Hitchcock MJ; Chen MS; Barkhimer DB; Cundy KC; Kent KM; Lacy SA; Lee WA; Li ZH; Mendel DB
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2387-91. PubMed ID: 7840575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced chemical stability of the intracellular prodrug, 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, relative to its parent compound, cidofovir.
    Oliyai R; Lee WA; Visor GC; Yuan LC
    Int J Pharm; 1999 Mar; 179(2):257-65. PubMed ID: 10053218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
    Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
    Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
    J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
    Smee DF; Bailey KW; Sidwell RW
    Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
    Smee DF; Bailey KW; Sidwell RW
    Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
    Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
    Coen N; Duraffour S; Naesens L; Krecmerová M; Van den Oord J; Snoeck R; Andrei G
    J Virol; 2013 Nov; 87(22):12422-32. PubMed ID: 24027315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.